Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 41kWORD 18k
24 July 2019
E-002425-19
Question for written answer E-002425-19
to the Commission
Rule 138
Sophia in 't Veld (Renew)

 Subject:  EU cross-border healthcare measures
 Answer in writing 

On 4 June 2019, the European Court of Auditors (ECA) published a special report on EU actions for cross-border healthcare. In its report, the ECA concluded that despite cooperation between the Member States having increased thanks to the EU’s cross-border healthcare measures, the benefits for patients are still limited. It therefore made recommendations focusing on the Commission’s support for National Contact Points to improve the provision of information, cross-border exchanges of health data and EU measures on rare diseases(1).

1. Does the Commission acknowledge that EU cross-border healthcare measures need to be better managed by the Commission in order for the Cross-Border Healthcare Directive to be fully effective?

2. Can it give a detailed reply to each of the three recommendations made by the ECA?

3. What immediate, concrete action will it take in response to the ECA’s recommendations so as to ensure that EU patients benefit more from cross-border healthcare?

(1)https://www.eca.europa.eu/Lists/ECADocuments/SR19_07/SR_HEALTH_CARE_EN.pdf

Last updated: 5 August 2019Legal notice - Privacy policy